Hoover Financial Advisors’s Biogen BIIB Stock Holding History

Hoover Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	-$1K	–	648
2021 Q1	$1K	Buy	+3	New	+$809	﹤0.01%	552
2020 Q3	–	Sell	-3	Closed	-$1K	–	221
2020 Q2	$1K	Buy	+3	New	+$902	﹤0.01%	457

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hoover Financial Advisors's BIIB Position: Q2 2021 in Review

Hoover Financial Advisors sold out of Biogen (BIIB) in Q2 2021, closing a stake of 3 shares — an estimated $1K sold.

Hoover Financial Advisors first reported a position in BIIB in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 1,105 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Hoover Financial Advisors reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Hoover Financial Advisors sold 3 Biogen shares in Q2 2021, an estimated $1K.
Hoover Financial Advisors first reported a position in Biogen in Q2 2020 and held it in 2 quarters.
Hoover Financial Advisors's Biogen position peaked at $1K in Q1 2021.
1,105 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.